Sidley Austin LLP represented Novo Nordisk Inc. in the matter. Novo Nordisk (NYSE: NVO) announced its collaboration with Evotec SE (NASDAQ: EVO) to launch LAB eN² (pronounced Lab...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Bausch Health Companies Inc. in connection with the separation of its eye health business into a new publicly traded company, Bausch + Lomb...
You must be a Standard 1 Year member to access this content.
Sidley and Mayer Brown advised Eurazeo on the deal. Eurazeo announced its investment in Cranial Technologies. Eurazeo’s investment will support Cranial Technologies’ expansion across the U.S. and...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised LifePoint Health on the deal, while Debevoise & Plimpton LLP advised TPG Capital, Welsh, Carson, Anderson & Stowe and Kindred Healthcare LLC....
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Sixth Street and Goldman Sachs on the deal while Goodwin Procter LLP represented Datavant. Ropes & Gray represented New Mountain Capital and its...
You must be a Standard 1 Year member to access this content.
